Related Experiment Video
Updated: Jul 23, 2025
09:17
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.4K
Immune Profiling of Meningiomas
Justin Z Wang1, Farshad Nassiri2, Linda Bi3
1Division of Neurosurgery, Department of Surgery, The University of Toronto, Toronto, ON, Canada.
Advances in Experimental Medicine and Biology
|July 11, 2023
Summary
Aggressive meningiomas are challenging to treat. Understanding their immune microenvironment is crucial for developing new immunotherapy strategies against these brain tumors.
Area of Science:
- Neuro-oncology
- Immunology
- Tumor Biology
Background:
- Meningiomas are typically benign but a subset exhibits aggressive behavior and resistance to standard treatments.
- The immune system's role in tumor growth and treatment response is increasingly recognized across various cancers.
- Immunotherapy has shown promise in cancers like lung, melanoma, and glioblastoma.
Approach:
- This chapter reviews current research on the immune microenvironment of meningiomas.
- It focuses on characterizing the cellular and molecular components of this microenvironment.
- Potential immunological targets for future therapeutic interventions are identified.
Key Points:
- Meningiomas, despite their common benign classification, include aggressive subtypes resistant to conventional therapies.
- The tumor immune microenvironment (TIME) is a critical factor influencing meningioma progression and treatment outcomes.
- Deciphering the TIME is a prerequisite for evaluating immunotherapy efficacy in meningioma patients.
Conclusions:
- Further investigation into the meningioma immune microenvironment is essential.
- Identifying specific immunological targets could pave the way for novel immunotherapy clinical trials.
- Targeting the immune system offers a promising avenue for treating aggressive and refractory meningiomas.
